Michael Barbella, Managing Editor12.05.23
DiagnaMed Holdings Corp. has launched CERVAI Healthcare Provider Network, a partnership program to expand access to its brain health artificial intelligence (AI) platform for healthcare providers, including hospitals, doctor offices, medical clinics, research and clinical specialists in Canada and the United States.
A world first, CERVAI consists of a Brain Age Estimation and Brain Health Assessment tool. The Brain Age Estimation tool includes a novel electroencephalogram headset and machine-learning model. It integrates proprietary software into unified and standardized data recording protocols. The Brain Health Assessment tool generates clinician-observed measures and a brain health score. These combined allow users to be proactive in achieving their brain health goals. Future versions of CERVAI will incorporate OpenAI’s GPT platform to develop personalized treatment plans.
“As we near the commercial launch for CERVAI, our brain health AI platform, we are excited to build our network of healthcare providers seeking to provide value added services, research and clinical care for their patients who want to take control of their brain health. Similarly, we will soon launch additional network programs for enterprise organizations, athletic teams, and personal at-home use,” DiagnaMed Chairman/CEO Fabio Chianelli said.
The CERVAI Healthcare Provider Network partnership program currently is open for enrollment.
DiagnaMed Holdings Corp., a generative artificial intelligence healthcare company based in Vancouver, Canada, develops and commercializes proprietary brain health AI platform CERVAI.
A world first, CERVAI consists of a Brain Age Estimation and Brain Health Assessment tool. The Brain Age Estimation tool includes a novel electroencephalogram headset and machine-learning model. It integrates proprietary software into unified and standardized data recording protocols. The Brain Health Assessment tool generates clinician-observed measures and a brain health score. These combined allow users to be proactive in achieving their brain health goals. Future versions of CERVAI will incorporate OpenAI’s GPT platform to develop personalized treatment plans.
“As we near the commercial launch for CERVAI, our brain health AI platform, we are excited to build our network of healthcare providers seeking to provide value added services, research and clinical care for their patients who want to take control of their brain health. Similarly, we will soon launch additional network programs for enterprise organizations, athletic teams, and personal at-home use,” DiagnaMed Chairman/CEO Fabio Chianelli said.
The CERVAI Healthcare Provider Network partnership program currently is open for enrollment.
DiagnaMed Holdings Corp., a generative artificial intelligence healthcare company based in Vancouver, Canada, develops and commercializes proprietary brain health AI platform CERVAI.